The Leadership Team at Silence Therapeutics Plc is responsible for setting the strategic direction and vision of the company, overseeing the development and execution of its RNA interference gene therapeutic technologies. This diverse team, consisting of leaders from technical operations, medical research, finance, drug discovery, and regulatory affairs, collaboratively drives innovation and ensures that projects align with business goals while navigating the complex landscape of biopharmaceutical development.
View all